U.S., March 26 -- Following UK government funding of US$1.2mn (March 6), Mologic Ltd. has begun the validation process of its point-of-need COVID-19 diagnostic tests.

Alongside global partners, Mologic has been building on its experience of developing a rapid test kit for Ebola, to develop a point-of-need hand held diagnostic test for the Coronavirus (COVID-19).

The availability of a fast and reliable diagnostic test for the virus has been marked as a critical opportunity to support in the control of the pandemic and curb the number of cases worldwide.

"Completion of the first prototypes is a significant step in Mologic's development of a rapid diagnostic test for COVID-19 and we are proud of our team's achievement in reaching this poi...